Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.04 USD
Change Today +0.10 / 5.15%
Volume 43.9K
VRML On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gordon Whiteley Ph.D.

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

----

Background*

Dr. Gordon Whiteley, PhD. serves as Director of the Antibody Characterization Lab for SAIC-Frederick, a part of the Clinical Proteomics Technologies for Cancer Initiative of the National Cancer Institute Director. Prior to coming to SAIC, Dr. Whiteley served as Vice President of Research and Development at PB Diagnostics / Dade-Behring where he was part of the original development team responsible for the development and commercialization of tests for a wide variety ...

Read Full Background

Corporate Headquarters*

Building III
Austin, Texas 78738

United States

Phone: 512-519-0400
Fax: 512-439-6980

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
University of Toronto

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRML:US $2.04 USD +0.10

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gon-Emon Kurihara President and Representative Director
Jeol Ltd.
--
Russell Cummings Chief Executive Officer, Executive Director and Member of Investment Committee
Imperial Innovations Group plc
403.0K GBP
Christopher J. Moreau Chief Executive Officer, President and Non Independent Director
Miraculins Inc.
C$216.7K
Rene A. Schena Chairman and Chief Executive Officer
Arrayit Corporation
$78.8K
Jan Groen Ph.D.Chief Executive Officer, President and Executive Director
MDxHealth SA
€491.1K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERMILLION INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.